anyone facing tech issues with cmc markets?

First 218 Last

Share
Profile

Follow
ooseven

20 Posts.

15/01/24

11:46

Post #: 71880833
Share

Originally posted by Silent-Bubbles: ↑

So then plenty of reasons to ' BLOCK ' the deal from an on market raid. And that has been what we've seen recently in the Lithium space and when its pretty much been on the decline. LTR , WC8 , AZS etc.... Lets see if ' Sovereignty ' is also a key here for Iron Ore. We know there has been enough precedence of history of Chinese Interest here .... so lets see what happens from here.

Yeah so I agree that that is what we should see happening more ....., if its going to happen at all. In my view though , surely after only 10 weeks from launching its DFS and 12 from updating on the PAC venture this couldn't be the FIRST and FINAL ....as well as BEST offer

And I still say that the Port facilities , the handling , the storage , and the loading under the PAC venture is where the significant value attraction is. And these sorts of BULK minerals costs in Australia have been pretty much a closed shop in terms of obtaining any concrete historical annualized figures. And that represents $39 odd million of the DFS so you'd have to take that out in terms of CAPEX required right.

However if you look back on what we do know , these costs could translate easily into another $2 to $3 per tonne ...., and probably more if you expand out into the critical minerals spectrum.

So effectively you could look at the offer as being 100% on the CAPEX that Miracle is going to have to pay anyway....PLUS the savings through its grab at SRK's package. And if there prepared to go straight to 100% more on the CAPEX , then you know this must be worth far more due current market rates expected on Iron Ore and the ' Quality ' of the potential blend.

Expand

anyone facing tech issues with cmc markets?

CZR Price at posting: 36.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

There are more pages in this discussion • 378 more messages in this thread...

First 218 Last

Add CZR (ASX) to my watchlist

(20min delay)
Last 24.5¢		Change -0.025(9.26%)		Mkt cap ! $63.83M

Open	High	Low	Value	Volume
27.0¢	27.0¢	24.5¢	$16	60

Buyers (Bids)

No.	Vol.	Price($)
1	33279	24.5¢

Sellers (Offers)

Price($)	Vol.	No.
26.5¢	5000	1

View Market Depth

No.	Vol.	Price($)
1	33279	0.245
2	54000	0.240
2	102400	0.235
2	63000	0.225
2	9986	0.220

Price($)	Vol.	No.
0.265	5000	1
0.270	30415	2
0.275	36163	2
0.280	100000	2
0.285	5000	1

Last trade - 14.29pm 07/10/2024 (20 minute delay)

CZR (ASX) Chart

anyone facing tech issues with cmc markets?

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

anyone facing tech issues with cmc markets?

Top Stories

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News